Phase IIPeptide
Compound 61495
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061495
Risk Class
LOW
Last Audit
Mar 8, 2108
Research Abstract
Peptide candidate engineered for metabolic regulation initiatives with automated dossier coverage.
Compound 61495 is a peptide asset inside peptide innovation track initiatives, optimized for metabolic regulation and cardiometabolic recovery.
The dossier currently sits in phase ii with a low risk rating, meaning it is cleared for baseline monitoring protocols.
Supply records cite CAS AUTO-061495 with updates logged 2108-03-08.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Metabolic regulationCardiometabolic recovery
Nomenclature
CX-61495Peptide Program 61495
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061495
- [2] Operations Pulse • Peptide innovation track
- [3] Risk Governance Ledger • LOW clearance for COMPOUND-61495